MedTrace Logo

Ultra-Low Dose CT Denoising for Lung Nodule Detection

NCT03159377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2021-10-15

No results posted yet for this study

Summary

We will perform an ultra low-dose CT (ULDCT) in addition to a regular chest CT scan for adult patients undergoing a clinically indicated chest CT. Using a recently developed computationally efficient algorithm for the denoising of ULDCT scans after image reconstruction, we will compare the sensitivity, specificity and accuracy of lesion detection with the ULDCT as compared to the regular CT scan.

Conditions

  • Pulmonary Nodule, Multiple

Interventions

DEVICE

Ultra low dose chest CT

Performing an ultra low dose chest CT (ULDCT) in addition to a clinically indicated chest CT and assessing nodule detection with a recently developed denoising algorithm

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Edith M Marom, MD · Sheba Medical Center

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-04
Primary Completion
2018-01-31
Completion
2021-07-06
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03159377 on ClinicalTrials.gov